DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

LM Henricks, C Lunenburg, FM de Man, D Meulendijks, GWJ Frederix, Emma Kienhuis, GJ Creemers, A Baars, VO Dezentje, A L T Imholz, FJF Jeurissen, JEA Portielje, RLH Jansen, P Hamberg, AJ ten Tije, HJ Droogendijk, M Koopman, P Nieboer, MHW van de Poel, C MandigersH Rosing, JH Beijnen, E van Werkhoven, ABP van Kuilenburg, Ron van Schaik, Ron Mathijssen, JJ Swen, H Gelderblom, A Cats, HJ Guchelaar, JHM Schellens

Research output: Contribution to journalArticleAcademicpeer-review

175 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1459-1467
Number of pages9
JournalLancet Oncology
Volume19
Issue number11
DOIs
Publication statusPublished - 2018

Cite this